Inhibitor Therapeutics, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Inhibitor Therapeutics, Inc. (INTI) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $17.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $17.00K.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2023-12-31 | $17.00K 10-K · filed 2024-03-29 |